abstract |
A method for treating, preventing, inhibiting or ameliorating one or more diseases associated with N-type calcium channels is provided. The present invention includes 5-phenyl-1-phenyl-3- (2,2,6,6-tetramethyl-tetrahydro-pyran-4-yl) -1H-pyrazole derivatives which are N-type calcium channel blockers. Pharmaceutical composition. [Selection figure] None |